TEK

TEK
  • 文章类型: Journal Article
    原发性先天性青光眼(PCG)是导致视力损害和失明的主要原因之一,严重影响受影响儿童的生活质量。它的特征是视盘拔罐和由于眼内压升高而导致的神经节细胞损失。虽然大多数PCG患者表现出泪露,畏光,和角膜混浊的buthemos,表型表现的变异性并不少见。受PCG影响的个体的及时诊断和治疗变得与在其一生中保持视觉功能相关。大多数PCG病例是散发性或常染色体隐性遗传;然而,最近已经证明了由TEK基因突变引起的不完全显性常染色体显性形式.这里,我们描述了一组墨西哥TEK相关PCG患者的临床和突变特征.我们的结果支持TEK基因作为我们种族中疾病的重要原因的参与,并通过报告10种新的致病变异来扩大引起PCG的突变谱。
    Primary congenital glaucoma (PCG) is one of the leading causes of visual damage and blindness, severely affecting the quality of life of affected children. It is characterized by cupping of the optic disc and loss of ganglion cells due to elevated intraocular pressure. While most PCG patients exhibit epiphora, photophobia, and buphthalmos with corneal opacity, variability in phenotypic manifestations is not uncommon. Prompt diagnosis and treatment of PCG affected individuals becomes relevant to preserve visual function throughout their lives. Most PCG cases are sporadic or autosomal recessive; however, an incompletely dominant autosomal dominant form arising from mutations in the TEK gene has recently been demonstrated. Here, we describe the clinical and mutational features of a cohort of Mexican patients with TEK-related PCG. Our results support the involvement of the TEK gene as an important cause of the disease in our ethnic group and expand the mutational spectrum causing PCG by reporting 10 novel disease-causing variants.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    血管生成素-1(Ang-1)和血管内皮生长因子(VEGF)是血管生成的主要调节因子,通常在各种心血管疾病中被灭活。VEGF与ETS转录因子家族形成复合物,并通过下调多个基因发挥其作用。在VEGF-ETS复合体的靶基因中,有大量编码关键血管生成调节因子。VEGF-ETS复合物的磷酸化释放对这些血管生成调节因子的转录抑制,从而促进他们的表达。Ang-1与TEK相互作用,并且这种磷酸化释放可以由Ang-1-TEK信号通路调节。Ang-1-TEK通路参与VEGF基因的转录激活。总之,这些元件构成Ang-1-TEK-VEGF信号通路。此外,Ang-1在缺氧和炎症条件下被激活,导致TEK表达上调。升高的TEK水平导致VEGF-ETS复合物的形成,which,反过来,下调许多血管生成基因的表达。因此,Ang-1依赖性转录抑制是间接的。许多靶基因的表达降低可导致异常血管生成。受Ang-1-TEK-VEGF调控的靶基因与受Ang-1-TEK-TSP-1信号通路控制的靶基因之间存在显著重叠。机械上,这可以通过在靶基因启动子的ETS位点用TSP-1转录抑制复合物替换VEGF-ETS复合物来解释.此外,VEGF具有与ETS和DNA结合无关的非经典功能。其在TSP-1形成中的支持作用可能通过VEGF-CRL5-VHL-HIF-1α-VH032-TGF-β-TSP-1轴发挥。这篇综述评估了Ang-1-TEK-VEGF信号通路的调控机制,并探讨了其与Ang-1-TEK-TSP-1信号通路的显著重叠。
    Angiopoietin-1 (Ang-1) and Vascular Endothelial Growth Factor (VEGF) are central regulators of angiogenesis and are often inactivated in various cardiovascular diseases. VEGF forms complexes with ETS transcription factor family and exerts its action by downregulating multiple genes. Among the target genes of the VEGF-ETS complex, there are a significant number encoding key angiogenic regulators. Phosphorylation of the VEGF-ETS complex releases transcriptional repression on these angiogenic regulators, thereby promoting their expression. Ang-1 interacts with TEK, and this phosphorylation release can be modulated by the Ang-1-TEK signaling pathway. The Ang-1-TEK pathway participates in the transcriptional activation of VEGF genes. In summary, these elements constitute the Ang-1-TEK-VEGF signaling pathway. Additionally, Ang-1 is activated under hypoxic and inflammatory conditions, leading to an upregulation in the expression of TEK. Elevated TEK levels result in the formation of the VEGF-ETS complex, which, in turn, downregulates the expression of numerous angiogenic genes. Hence, the Ang-1-dependent transcriptional repression is indirect. Reduced expression of many target genes can lead to aberrant angiogenesis. A significant overlap exists between the target genes regulated by Ang-1-TEK-VEGF and those under the control of the Ang-1-TEK-TSP-1 signaling pathway. Mechanistically, this can be explained by the replacement of the VEGF-ETS complex with the TSP-1 transcriptional repression complex at the ETS sites on target gene promoters. Furthermore, VEGF possesses non-classical functions unrelated to ETS and DNA binding. Its supportive role in TSP-1 formation may be exerted through the VEGF-CRL5-VHL-HIF-1α-VH032-TGF-β-TSP-1 axis. This review assesses the regulatory mechanisms of the Ang-1-TEK-VEGF signaling pathway and explores its significant overlap with the Ang-1-TEK-TSP-1 signaling pathway.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    静脉畸形(VM)是最常见的血管畸形。TEK和PIK3CA是VM的因果基因,可能参与PI3K/AKT通路。然而,VM中TEK或PIK3CA突变的下游机制尚未完全了解.本研究旨在确定基因突变与临床病理特征之间的可能关联。回顾性临床,病态,并对114例VM患者进行了遗传学研究。TEK,PIK3CA,和TEK/PIK3CA联合突变在49(43%),13(11.4%),和2名(1.75%)患者,分别。与TEK和PIK3CA突变阴性VM(其他突变VM)相比,TEK突变VM更常见于年轻患者,并显示更频繁的皮肤受累和没有淋巴细胞聚集。在性别上没有观察到显著差异,发生的位置,畸形血管大小,血管密度,或VM基因型中血管平滑肌的厚度。免疫组织化学分析显示,磷酸化AKT(p-AKT)在TEK突变体VM中的表达水平高于PIK3CA突变体和其他突变体VM中的表达水平。所有VM基因型中p-mTOR及其下游效应子的表达水平均高于正常血管。空间转录组学揭示了参与“血管发育”的基因“细胞迁移的正调节”,和“细胞外基质组织”在TEK突变体VM中上调。在VM基因型之间观察到临床和病理特征的显着基因型-表型相关性,表明基因特异性效应。对VM中基因特异性作用的详细分析可以提供对潜在分子途径的见解和对靶向治疗的影响。
    Venous malformations (VMs) are the most common vascular malformations. TEK and PIK3CA are the causal genes of VMs, and may be involved in the PI3K/AKT pathway. However, the downstream mechanisms underlying the TEK or PIK3CA mutations in VMs are not completely understood. This study aimed to identify a possible association between genetic mutations and clinicopathological features. A retrospective clinical, pathological, and genetic study of 114 patients with VMs was performed. TEK, PIK3CA, and combined TEK/PIK3CA mutations were identified in 49 (43%), 13 (11.4%), and 2 (1.75%) patients, respectively. TEK-mutant VMs more commonly occurred in younger patients than TEK and PIK3CA mutation-negative VMs (other-mutant VMs), and showed more frequent skin involvement and no lymphocytic aggregates. No significant differences were observed in sex, location of occurrence, malformed vessel size, vessel density, or thickness of the vascular smooth muscle among the VM genotypes. Immunohistochemical analysis revealed that the expression levels of phosphorylated AKT (p-AKT) were higher in the TEK-mutant VMs than those in PIK3CA-mutant and other-mutant VMs. The expression levels of p-mTOR and its downstream effectors were higher in all the VM genotypes than those in normal vessels. Spatial transcriptomics revealed that the genes involved in \"blood vessel development\", \"positive regulation of cell migration\", and \"extracellular matrix organization\" were up-regulated in a TEK-mutant VM. Significant genotype-phenotype correlations in clinical and pathological features were observed among the VM genotypes, indicating gene-specific effects. Detailed analysis of gene-specific effects in VMs may offer insights into the underlying molecular pathways and implications for targeted therapies.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    背景:在原发性开角型青光眼(POAG)中,降低眼内压(IOP)是减缓视力丧失的唯一有效方法。Schlemm管(SC)是一种混合血管和淋巴管,可介导房水从眼前房引流。动物研究支持SC内皮血管生成素-TEK信号传导的重要性,最近的TIE1信号,维持正常的眼压。然而,目前缺乏对TIE1和TEK信号在降低IOP中的因果作用的人类基因支持.
    方法:获得了血浆可溶性TIE1(sTIE1)蛋白水平的GWAS汇总统计数据(N=35,559),可溶性TEK(sTEK)蛋白水平(N=35,559),IOP(N=139,555)和POAG(病例=16,677,对照=199,580)。进行孟德尔随机化(MR)以评估遗传代理的TIE1和TEK蛋白水平与IOP和POAG责任的关联。如果获得了重要的MR估计,进行了遗传共定位,以评估TIE1/TEK信号传导和结局相关的共有因果变异(PPshared)与不同因果变异(PPdistinct)的概率.利用公开的单核RNA测序数据来研究TIE1和TEK在人眼前段中的差异表达。
    结果:与IOP降低相关的遗传代理TIE1信号和TEK信号增加(sTIE1每SD增加-0.21mmHg,95%CI=-0.09至-0.33mmHg,P=6.57×10-4,sTEK每减少0.14mmHg,95%CI=-0.03至-0.25mmHg,P=0.011),但不是POAG责任。共同定位分析发现,TIE1和IOP的共享因果变异的概率高于TEK和IOP(TIE1的PPshared/(PPdistinctPPshared)=0.98,TEK的0.30)。在前段,TIE1和TEK在SC中优先表达,淋巴管,和血管内皮。
    结论:这项研究为TIE1和TEK信号在调节IOP中的因果作用提供了新的人类基因支持。这里,与TEK相比,来自顺式-MR和共定位分析的综合证据对TIE1作为潜在的降低IOP的治疗靶点提供了更强的支持.
    In primary open-angle glaucoma (POAG), lowering intraocular pressure (IOP) is the only proven way of slowing vision loss. Schlemm\'s canal (SC) is a hybrid vascular and lymphatic vessel that mediates aqueous humour drainage from the anterior ocular chamber. Animal studies support the importance of SC endothelial angiopoietin-TEK signalling, and more recently TIE1 signalling, in maintaining normal IOP. However, human genetic support for a causal role of TIE1 and TEK signalling in lowering IOP is currently lacking.
    GWAS summary statistics were obtained for plasma soluble TIE1 (sTIE1) protein levels (N = 35,559), soluble TEK (sTEK) protein levels (N = 35,559), IOP (N = 139,555) and POAG (Ncases = 16,677, Ncontrols = 199,580). Mendelian randomization (MR) was performed to estimate the association of genetically proxied TIE1 and TEK protein levels with IOP and POAG liability. Where significant MR estimates were obtained, genetic colocalization was performed to assess the probability of a shared causal variant (PPshared) versus distinct (PPdistinct) causal variants underlying TIE1/TEK signalling and the outcome. Publicly available single-nucleus RNA-sequencing data were leveraged to investigate differential expression of TIE1 and TEK in the human ocular anterior segment.
    Increased genetically proxied TIE1 signalling and TEK signalling associated with a reduction in IOP (- 0.21 mmHg per SD increase in sTIE1, 95% CI = - 0.09 to - 0.33 mmHg, P = 6.57 × 10-4, and - 0.14 mmHg per SD decrease in sTEK, 95% CI = - 0.03 to - 0.25 mmHg, P = 0.011), but not with POAG liability. Colocalization analysis found that the probability of a shared causal variant was greater for TIE1 and IOP than for TEK and IOP (PPshared/(PPdistinct + PPshared) = 0.98 for TIE1 and 0.30 for TEK). In the anterior segment, TIE1 and TEK were preferentially expressed in SC, lymphatic, and vascular endothelium.
    This study provides novel human genetic support for a causal role of both TIE1 and TEK signalling in regulating IOP. Here, combined evidence from cis-MR and colocalization analyses provide stronger support for TIE1 than TEK as a potential IOP-lowering therapeutic target.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    肺纤维化(PF)是一种快速发展且不可逆的疾病,目前可用的临床药物类型有限且效率低下。在我们之前的研究中,我们观察到钩藤碱(Rhynchophylline,Rhy)阻碍肌腱粘连并刺激受损肌腱结构的愈合。考虑到粘附形成和PF之间的类似机制,我们探讨了Rhy在PF中的作用。
    通过细胞计数试剂盒-8(CCK-8)测定来测试Rhy的细胞毒性。通过Westernblot(WB)评估PF的程度,Masson和苏木精-伊红(HE)染色,和羟脯氨酸定量。通过乳化超声技术制备负载Rhy的纳米颗粒,并通过透射电子显微镜(TEM)和扫描电子显微镜(SEM)进行表征。使用上清液的吸光度值测试装载Rhy的纳米颗粒的释放。进行转录组测序以确定Rhy的下游靶标和途径,然后由WB验证。
    体外,Rhy降低转化生长因子β1(TGF-β1)诱导的纤维连接蛋白(FN)异常过表达,胶原蛋白I(ColI),α-平滑肌肌动蛋白(α-SMA)在人肺成纤维细胞(HFL1)细胞中呈剂量依赖性。在体内,我们证实(通过Masson染色)腹腔注射Rhy以剂量依赖的方式减少了胶原沉积和纤维化区域。我们的结果表明,载Rhy纳米粒子气管内喷雾直观地缩小胶原沉积,胶原沉积和纤维化区域缩小(Masson和HE染色),并降低纤维化相关标志物(WB)的表达。同时,肺指数值和羟脯氨酸含量明显低于博莱霉素(BLM)治疗组。通过转录测序分析,我们确定受体酪氨酸激酶(TEK)-磷脂酰肌醇3激酶/蛋白激酶B(PI3K/AKT)是Rhy的下游靶标和途径。还观察到Rhy可以逆转TGF-β1诱导的TEK和磷酸化AKT(p-AKT)升高的表达。
    我们的发现表明Rhy通过抑制TEK-PI3K/AKT信号通路限制了PF的进展。因此,这种Rhy的持续释放系统是一种高效的限制PF的疗法,应该开发。
    UNASSIGNED: Pulmonary fibrosis (PF) is a rapidly progressing and irreversible disease, and the currently available types of clinical drugs are limited and inefficient. In our previous study, we observed that Rhynchophylline (Rhy) hindered tendon adhesion and stimulated the healing of injured tendon structures. Considering the similar mechanisms between adhesion formation and PF, we explored the roles of Rhy in PF.
    UNASSIGNED: The cytotoxicity of Rhy was tested by a Cell Counting Kit-8 (CCK-8) assay. The degree of PF was evaluated by Western blot (WB), Masson and hematoxylin-eosin (HE) staining, and hydroxyproline quantification. The Rhy-loaded nanoparticles were prepared through an emulsification sonication technique and characterized by transmission electron microscopy (TEM) and scanning electron microscopy (SEM). The release of the Rhy-loaded nanoparticles was tested using the absorbance value of the supernatant. Transcriptome sequencing was performed to determine the downstream target and pathway of Rhy, which was then verified by WB.
    UNASSIGNED: In vitro, Rhy decreased Transforming Growth Factor Beta 1 (TGF-β1)-induced abnormal overexpression of fibronectin (FN), collagen I (Col I), α-smooth muscle actin (α-SMA) in a dose-dependent manner in human lung fibroblast (HFL1) cells. In vivo, we confirmed (through Masson staining) that the intraperitoneal injection of Rhy reduced collagen deposition and the fibrotic area in a dose-dependent manner. Our results indicated that the Rhy-loaded nanoparticles intratracheal spray intuitively narrowed collagen deposition, shrank collagen deposition and the fibrotic area (Masson and HE staining), and reduced the expression of fibrosis-related markers (WB). Meanwhile, the lung index value and hydroxyproline content were markedly lower than the bleomycin (BLM)-treated group. By transcriptional sequencing analysis, we identified Receptor Tyrosine Kinase (TEK)-Phosphatidylinositol 3-Kinase/Protein Kinase B (PI3K/AKT) as the downstream target and pathway of Rhy. It was also observed that Rhy could reverse the TGF-β1-induced TEK and phosphorylated AKT (p-AKT) elevated expression.
    UNASSIGNED: Our findings indicate that Rhy constrained PF progression by inhibiting TEK-PI3K/AKT signaling pathway. Hence, this sustainable release system of Rhy is a highly effective therapy to limit PF and should be developed.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:肺腺癌(LUAD)发病率高,预后差,和多个circRNAs(circRNAs)已被发现调节LUAD。
    目的:本研究集中于hsa_circ_0070661在LUAD中的作用和机制。
    方法:收集我院38例诊断为LUAD的患者的LUAD组织和癌旁组织。Hsa_circ_0070661,miR-556-5p和TEK受体酪氨酸激酶(TEK)水平使用蛋白质印迹和RT-qPCR进行评估,并通过荧光素酶报告基因和RIP检测来检测靶向关系。细胞迁移,生存能力,凋亡相关蛋白,通过Transwell评估(Bcl-2和Bax)和体内肿瘤生长,CCK-8,蛋白质印迹和异种移植试验,分别。
    结果:结果表明LUAD细胞系和组织中hsa_circ_0070661和TEK的下调,而miR-556-5p的上调。hsa_circ_0070661上调抑制了生存能力,LUAD细胞的迁移和肿瘤生长,促进细胞凋亡。Hsa_circ_0070661可直接靶向miR-556-5p上调LUAD中的TEK表达。MiR-556-5p上调促进了LUAD细胞的恶性表型,逆转了hsa_circ_0070661过表达的抗癌作用,而TEK上调抑制了LUAD进展,并在一定程度上根除了miR-556-5p上调的促癌作用。
    结论:Hsa_circ_0070661海绵miR-556-5p通过调节TEK抑制LUAD发育,为LUAD的临床治疗提供了一个有前景的分子靶点。
    BACKGROUND: Lung adenocarcinoma (LUAD) has a high incidence and poor prognosis, and multiple circRNAs (circRNAs) have been found to regulate LUAD.
    OBJECTIVE: This study focuses on the effect and mechanism of hsa_circ_0070661 in LUAD.
    METHODS: LUAD tissues and para-cancerous tissues were collected from 38 patients diagnosed with LUAD in our hospital. Hsa_circ_0070661, miR-556-5p and TEK Receptor Tyrosine Kinase (TEK) levels were evaluated using western blotting and RT-qPCR, and the targeting relationship was detected by luciferase reporter and RIP assays. Cell migration, viability, apoptosis-related proteins, (Bcl-2 and Bax) and tumor growth in vivo were assessed by Transwell, CCK-8, western blotting and xenograft assays, respectively.
    RESULTS: Results indicated downregulation of hsa_circ_0070661 and TEK in LUAD cell lines and tissues, whereas upregulation of miR-556-5p. Hsa_circ_0070661 upregulation restrained the viability, migration and tumor growth of LUAD cells, and promoted apoptosis. Hsa_circ_0070661 could directly target miR-556-5p to upregulate TEK expression in LUAD. MiR-556-5p upregulation promoted the malignant phenotypes of LUAD cells and reversed the anti-cancer effect of hsa_circ_0070661 overexpression, while TEK upregulation inhibited LUAD progression and somewhat eradicated the cancer-promoting effect of miR-556-5p upregulation.
    CONCLUSIONS: Hsa_circ_0070661 sponges miR-556-5p to inhibit LUAD development via regulating TEK, providing a promising molecular target for LUAD clinical therapy.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    散发性血管畸形(VM)是由几种基因的体细胞突变引起的大量血液和淋巴管疾病,主要调节RAS/MAPK/ERK和PI3K/AKT/mTOR途径。我们对43例散发性VM患者进行了横断面研究,他们在我们中心接受了深度靶向下一代测序的分子诊断。临床和影像学特征与病变组织中鉴定的序列变异相关。9例毛细血管畸形和过度生长(CMO)患者中有6例患有复发性GNAQ体细胞突变p.Arg183Gln,而两个有PIK3CA突变。出乎意料的是,11例弥漫性CM伴过度生长(DCMO)中8例携带已知的PIK3CA突变,其余3个有致病性GNA11变异。在巨脑症-CM-polymicrogyria(MCAP)患者中发现了复发的PIK3CA突变,CLOVES,和Klippel-Trenaunay综合征.有趣的是,PIK3CA体细胞突变不仅与MCAP和CLOVES中的手/足异常相关,而且在CMO和DCMO。两名患有蓝色橡皮泡痣综合征的患者携带双重体细胞TEK突变,其中两个以前没有描述。此外,描述了由于RASA1马赛克致病变体而导致的ParkesWeber综合征(PWS)的新散发病例。最后,一个患有轻度PWS的女孩和另一个被诊断为CMO的女孩携带致病性KRAS体细胞变异,显示与KRAS突变相关的表型特征的变异性。总的来说,我们的发现扩展了散发性VM的临床和分子谱,并显示基因检测对准确诊断和新兴靶向治疗的相关性。
    Sporadic vascular malformations (VMs) are a large group of disorders of the blood and lymphatic vessels caused by somatic mutations in several genes-mainly regulating the RAS/MAPK/ERK and PI3K/AKT/mTOR pathways. We performed a cross-sectional study of 43 patients affected with sporadic VMs, who had received molecular diagnosis by high-depth targeted next-generation sequencing in our center. Clinical and imaging features were correlated with the sequence variants identified in lesional tissues. Six of nine patients with capillary malformation and overgrowth (CMO) carried the recurrent GNAQ somatic mutation p.Arg183Gln, while two had PIK3CA mutations. Unexpectedly, 8 of 11 cases of diffuse CM with overgrowth (DCMO) carried known PIK3CA mutations, and the remaining 3 had pathogenic GNA11 variants. Recurrent PIK3CA mutations were identified in the patients with megalencephaly-CM-polymicrogyria (MCAP), CLOVES, and Klippel-Trenaunay syndrome. Interestingly, PIK3CA somatic mutations were associated with hand/foot anomalies not only in MCAP and CLOVES, but also in CMO and DCMO. Two patients with blue rubber bleb nevus syndrome carried double somatic TEK mutations, two of which were previously undescribed. In addition, a novel sporadic case of Parkes Weber syndrome (PWS) due to an RASA1 mosaic pathogenic variant was described. Finally, a girl with a mild PWS and another diagnosed with CMO carried pathogenic KRAS somatic variants, showing the variability of phenotypic features associated with KRAS mutations. Overall, our findings expand the clinical and molecular spectrum of sporadic VMs, and show the relevance of genetic testing for accurate diagnosis and emerging targeted therapies.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    Segmental overgrowth has been widely described in patients with congenital vascular anomalies. However, segmental undergrowth has been poorly characterized, and no large series of patients have been published. We present the clinical and molecular characteristics a cohort of 37 patients with vascular malformations and segmental undergrowth. True undergrowth was only considered when the musculoskeletal system was involved to avoid confusion with other causes of segmental reduction, as in lipodystrophy or the long-term osteopenia seen in patients with Servelle-Martorell syndrome. Deep high-throughput sequencing was performed in tissue samples from 20 patients using a custom panel. We identified three groups: undergrowth associated with (1) venous, (2) capillary-venous, and (3) lymphatic-capillary-venous malformations. Congenital or early childhood onset undergrowth can occur with or without associated overgrowth. Different likely pathogenic or pathogenic variants were detected in 13 of 20 (65%) tissue samples in the PIK3CA, TEK, GNAQ, or GNA11 genes. In conclusion, the eponymous Servelle-Martorell syndrome should not be used as a synonym for undergrowth. Segmental undergrowth should be considered a characteristic associated with vascular malformations. Patients with PIK3CA variants show all different combinations of overgrowth and undergrowth. Thus, the term PROS (PIK3CA-related overgrowth spectrum) does not cover the entire spectrum.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    目的:新的证据表明,细胞毒性治疗可以促进耐药和转移,同时抑制原发肿瘤的生长。到目前为止,然而,潜在机制尚不清楚.这里,我们旨在研究阿霉素(ADR)治疗对乳腺癌细胞的促转移作用,并探讨这些作用的潜在机制.
    方法:使用高通量RNA-seq和差异基因表达分析鉴定MCF-7和抗ADR的MCF-7乳腺癌细胞之间的差异表达基因。体外transwell和划痕伤口愈合试验,和体内自发转移模型用于研究乳腺癌细胞的转移潜力。使用启动子活性研究SIRT7和TEK表达之间的关系,电泳迁移率偏移(EMSA),CHIP-qPCR和Co-IP测定。
    结果:使用转录组测序,我们确定了两个关键基因(SIRT7和TEK),它们可能有助于ADR对乳腺癌细胞的促转移作用.SIRT7通过在TEK启动子处诱导H3K18的去乙酰化而充当TEK的负调节剂。通过转录因子预测和双荧光实验,我们发现EST-1可以与TEK启动子结合。EST-1的敲低消除了由SIRT7的上调介导的TEK的转录抑制。Co-IP显示SIRT7在乳腺癌细胞中直接与EST-1相互作用,表明SIRT7可以通过直接结合EST-1在TEK启动子区域诱导H3K18脱乙酰化。体外和体内结果表明,SIRT7的过表达或TIE2的抑制显着降低了ADR依赖性乳腺癌细胞的侵袭/转移。
    结论:我们的研究结果表明,ADR治疗可能以SIRT7/TEK(TIE2)依赖的方式加速乳腺癌转移。
    OBJECTIVE: Emerging evidence suggests that cytotoxic therapy may promote drug resistance and metastasis while inhibiting the growth of primary tumors. As yet, however, the underlying mechanisms remain unclear. Here, we aimed to investigate the pro-metastatic effects of adriamycin (ADR) therapy on breast cancer cells and to investigate the mechanisms underlying these effects.
    METHODS: Differentially expressed genes between MCF-7 and ADR-resistant MCF-7 breast cancer cells were identified using high-throughput RNA-seq and differential gene expression analyses. In vitro transwell and scratch wound-healing assays, and an in vivo spontaneous metastasis model were used to study the metastatic potential of the breast cancer cells. The relationship between SIRT7 and TEK expression was studied using promoter activity, electrophoretic mobility shift (EMSA), CHIP-qPCR and Co-IP assays.
    RESULTS: Using transcriptome sequencing, we identified two key genes (SIRT7 and TEK) that might contribute to the pro-metastatic effect of ADR on breast cancer cells. SIRT7 acted as a negative regulator for TEK by inducing deacetylation of H3K18 at the TEK promoter. Through transcription factor prediction and double fluorescence experiments, we found that EST-1 could bind to the TEK promoter. Knockdown of EST-1 removed the transcriptional inhibition of TEK that was mediated by up-regulation of SIRT7. Co-IP showed that SIRT7 interacts directly with EST-1 in breast cancer cells, indicating that SIRT7 may induce H3K18 deacetylation at the TEK promoter region by directly binding to EST-1. In vitro and in vivo results showed that overexpression of SIRT7 or inhibition of TIE2 significantly reduced ADR-dependent breast cancer cell invasion/metastasis.
    CONCLUSIONS: Our findings suggest that ADR therapy may accelerate breast cancer metastasis in a SIRT7/TEK(TIE2) dependent manner.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    BACKGROUND: The use of plants in rituals is a little explored corner of biocultural diversity which has developed through time within a complex socio-ecological system. Indeed, rituals are complex interactions between humans and biodiversity shaped by history, culture, and ethnic belonging. Yet, in Western Ukraine, such rituals were forbidden for over 50 years (1939-1991). The current revival of rituals by rural inhabitants is an untapped reservoir of local ecological knowledge. The aim of the present study was to identify the ritual use of wild and cultivated plants in two regions of Western Ukraine, Bukovina and Roztochya, and to compare the findings with historical data. Moreover, we analyzed attitudes toward the ritual use of plants and interactions with the local environment.
    METHODS: We conducted 31 in-depth semi-structured interviews among Orthodox Hutsuls of Bukovina and 16 interviews among Greek Catholic rural inhabitants of Roztochya during summer 2018 focusing on the ritual uses of plants.
    RESULTS: We documented  28 plant taxa among Bukovinian Hutsuls and 58 plant taxa among inhabitants in Roztochya that were used in 7 religious festivals (of which two were celebrated differently in the two communities). Plants were mainly used in bouquets, but also for decorating churches and houses or in fruit baskets. In both communities, almost 25% of the interviewees could not name the plants they collected for bouquets, but rather referred to \"just beautiful green herbs\" one can get in meadows, forests, and gardens. Comparison with historical data shows a smaller number of taxa currently used (wild taxa have been lost), yet the persistence of 18 taxa used both now and a century ago.
    CONCLUSIONS: Contemporary practices concerning the use of plants in Christian rituals in Bukovina and Roztochya can be contextualized in the broader phenomenon of the revitalization of traditional environmental knowledge and practices that have characterized Europe over the past 30 years and in particular Eastern Europe after socialism. The current religious use of plants is to a certain extent the revitalization of historical rituals supported by various internal (knowledge from older generations) and external (church authorities and fashion in the region) drivers. Further research should address changes in regions with longer and more severe prohibition of religious practices and their revival.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

       PDF(Pubmed)

公众号